View drug registration information details.


ItemsRegistration information
ID401
No401
Brand NameABEVMY 400
IngredientsBEVACIZUMAB (R-DNA ) 400 MG/16 ML
Dosage FormSOLUTION FOR INFUSION
Primary PackagingVIAL
StorageSTORE AT TEMPERATURE BETWEEN 2 - 8 C
Shelf Life2 YEARS
Pack SizeBOX OF 1 VIAL X 16 ML
Dispensing CategoryPrescription only
ATC ClassificationL01XC07
Pharmaceutical ClassANTINEOPLASTICS
IndicationsTREATMENT OF ADULT PATIENTS WITH METASTATIC CARCINOMA OF TH E COLON OR RECTUM (IN COMBINATION WITH FLUOROPYRIMIDINE BASED CHEMOTHERAPY)
ContraindicationsHYPERSENSITIVITY TO API OR EXCIPIENT, CHINESE HAMSTER OVARY CELL PRODUCT, PREGNANCY
Side EffectsGASTROINJTESTINAL PERFORATIONS AND FISTULAE, WOUD HEALING COMPLICATION, HAEMORRHAGE, ARTERIAL THROMBOEMBOLISM, HYPERTENTION, PROTEINURIA, OVARIAN FAILURE, POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME
Unit Price
EDL Yes
DescriptionCLEAR TO SLIGHTLY OPALESCENT, COLORLESS TO PALE BROWN LIQUID
Note
License OwnerDKSH LAOS COMPANY LIMITED
ManufacturerBIOCON LIMITED
CountryINDIA
Import Registration NoKTK/28D/7/2006
Import Registration Date2006-04-28
ActivityCERTIFICATE RELEASED
Applied Date2020-11-27
FDD Registration No08 I 5269/22
FDD Registration Date2022-08-26
Expiry Date2025-08-25

Back to drug list